nRichDX

nRichDX is an Irvine, California-based biotechnology company revolutionizing liquid biopsy sample preparation.

We specialize in delivering significantly higher yields of cfDNA, cfRNA, and CTCs – often exceeding those of existing systems – through our proprietary Revolution Sample Prep Platform.

nRichDX solves a critical challenge in precision medicine: inaccurate diagnostic results due to insufficient target material in liquid biopsies. Our innovative, semi-automated system, combined with the Hamilton Microlab STAR liquid handler, provides scalable, automated solutions for enhanced test sensitivity and reliability.

We are a trusted partner to leading research institutions and diagnostic labs, including Johns Hopkins University and Dartmouth, and are committed to advancing the field of liquid biopsy through continuous innovation and rigorous validation.